- Sectors
- Industrial technology
- DeepTech
DeepTech
DeepTech is the catch-all term for venture-backed companies built on unproven scientific and engineering advances - quantum computing, nuclear fusion, advanced materials, synthetic biology, neuromorphic computing, photonics - rather than on application-layer software. The defining characteristic is long capital cycles (often 10-20 years from founding to revenue), high technical risk, and a heavy reliance on government and strategic capital alongside venture funding. The DeepTech category absorbed an estimated $80B globally in 2024 across all sub-themes per Dealroom data, and remains one of the few areas where US, EU and Chinese state programmes are explicitly funding private companies at scale.
The sector spans quantum computing, nuclear fusion, synthetic biology, advanced materials and metamaterials, neuromorphic and photonic computing, and brain-computer interfaces.
Revenue comes from government and defence research contracts, hardware-as-a-service subscriptions (quantum cloud access), one-off pilot deployments to industrial and pharma customers, IP licensing, and milestone-based partnership revenue with strategic corporate partners.
DeepTech is part of Industrial technology.
$154B
Global market size
1463
Public companies
Key VC investors
Key strategic buyers
How DeepTech companies monetize?
Deeptech companies monetize through government research contracts, quantum-as-a-service subscriptions and strategic partnership milestones.
Government research contracts
DoE, DARPA, ARPA-E, ARIA UK, EU Horizon and Chinese government funding for long-cycle research. The dominant revenue line for fusion, quantum and advanced materials companies pre-commercial.
Quantum-as-a-service
Cloud access subscriptions to quantum computers via AWS Braket, Azure Quantum and IBM Q. IBM, Quantinuum and IonQ all report this revenue line.
Pilot deployments
One-off engineering contracts with pharma, financial services and energy customers exploring DeepTech use cases. Revenue lumpy and customer-specific.
IP licensing
Royalties on patented chemistries, materials or algorithms used by larger industrial partners. Standard for advanced-materials and biotech-adjacent DeepTech.
Strategic partnership revenue
Milestone payments and co-development revenue from corporate partners (Boeing, Pfizer, JP Morgan, Mitsubishi). Validates the technology and funds R&D.
Equipment sales
One-off sales of bench-scale hardware (cryostats, photonic chips, fusion components) to research labs and other DeepTech companies. Small but recurring.
DeepTech valuations in May 2026
Public DeepTech comps trade at 4.2x EV/Revenue. Median revenue multiple across DeepTech M&A deals was 2.9x in the last 12 months. Median revenue multiple across DeepTech VC rounds was 19x in the last 12 months.
4.2x
Median EV/Revenue as of May 2026 for public DeepTech companies
24x
NVIDIA is the highest valued public DeepTech company based on EV/Revenue (excluding outliers)
2.9x
Median EV/Revenue across DeepTech M&A deals in the last 12 months
19x
Median EV/Revenue across DeepTech VC rounds in the last 12 months
DeepTech market segments
Deeptech spans quantum computing, nuclear fusion and brain-computer interfaces.
Quantum computing hardware
Companies building gate-model and analog quantum computers, including superconducting, trapped-ion, photonic and neutral-atom architectures. IBM, Google Quantum AI, IonQ (NYSE: IONQ), Rigetti (NASDAQ: RGTI), PsiQuantum, Atom Computing and Quantinuum lead.
Nuclear fusion
Private fusion energy companies pursuing tokamak, stellarator, magnetised target and inertial confinement paths. Commonwealth Fusion Systems (raised $1.8B Series B in 2021), Helion (raised $425M in 2024 with $1.7B more committed pending milestones), TAE Technologies, Tokamak Energy and Zap Energy are the reference names.
Synthetic biology platforms
Engineered microbes and platforms for industrial-scale fermentation, novel materials and protein production. Ginkgo Bioworks (NYSE: DNA, traded down 95%+ from SPAC peak), Zymergen (acquired by Ginkgo in 2022), Twist Bioscience and Asimov sit here.
Advanced materials & metamaterials
Engineered materials for batteries, sensors, optics and structural applications. Sila Nano (raised $375M Series H in 2024), Group14 Technologies (silicon battery), Lyten and Metalenz lead.
Neuromorphic & photonic computing
Non-von Neumann compute architectures for AI inference and high-performance computing. Lightmatter, Ayar Labs, Celestial AI (raised $175M Series C in 2025), Rain AI and BrainChip lead.
Brain-computer interfaces
Implanted and non-invasive BCI hardware for medical and consumer applications. Neuralink (private, valued $5B in 2023; first human implant 2024), Synchron, Paradromics and Precision Neuroscience are the reference names.
Fractional CFO, financial modelling and deal advice for DeepTech companies
See how Flow helps DeepTech founders.
We speak founders' language and have great operational understanding of DeepTech businesses.
Book an intro call - we'll look under the hood and recommend concrete next steps.
Fractional CFO
For founders who want to improve their FP&A functions, build an investor-ready financial model, and prepare for the next VC round.

Capital raising
For bootstrapped and already-VC-backed entrepreneurs who are looking to raise late stage venture or growth capital.

M&A
For category-leading technology companies who are exploring exit alternatives with either financial or strategic acquirers.

Key DeepTech KPIs to track
Capital raised, cash runway, technical milestone progress and government contract backlog are the metrics investors track in deeptech.
| KPI | Definition |
|---|---|
| Capital raised | Cumulative equity and debt funding since inception. The first metric for any DeepTech company because revenue is typically immaterial pre-commercial. |
| Cash runway | Months of operating cash at current burn rate. The most-watched metric because most DeepTech companies are years from positive cash flow. |
| Revenue growth | Year-on-year revenue change. Standard once a company has crossed into commercial deployment. |
| Government contract backlog | Signed but undelivered government and DoD research contracts. The cleanest revenue forward-indicator for DeepTech pre-commercial. |
| Technical milestone progress | Independently verified progress against scientific milestones (qubit fidelity, fusion energy gain, materials yield). The proxy investors use in absence of revenue. |
| Patents filed / granted | IP portfolio size and trajectory. Critical for materials and biotech-adjacent DeepTech where royalty business models depend on it. |
| Strategic partnership count | Active corporate partnerships with credible industrial or scientific partners. The signal of commercial pull-through ahead of revenue. |
| Talent density | PhD or equivalent share of headcount. The leading indicator of execution capability in DeepTech and tracked by sophisticated investors during diligence. |
Main DeepTech players globally
The most active deeptech companies and category leaders globally.
| Company | HQ | Overview |
|---|---|---|
IBM Quantum ibm.com | Armonk | Largest cumulative investor in quantum computing among public companies; shipped the 1,121-qubit Condor processor in 2023 and the 156-qubit Heron in 2024. Quantum-as-a-service via IBM Quantum Network. |
IonQ ionq.com | College Park | Listed on NYSE as IONQ. First pure-play quantum hardware company to go public (via SPAC in 2021). Trapped-ion architecture; signed multi-year contracts with US Air Force and DARPA in 2024-25. |
PsiQuantum psiquantum.com | Palo Alto | Photonic quantum computing company; signed AUD 940M deal with Australian and Queensland governments to build a utility-scale machine in Brisbane (announced 2024). Last private valuation around $3B. |
Atom Computing atom-computing.com | Berkeley | Neutral-atom quantum computing developer. Demonstrated a 1,180-qubit machine in 2023 with Microsoft; raised $60M Series B in 2022. |
Commonwealth Fusion Systems cfs.energy | Devens | Tokamak-based fusion company spun out of MIT. Raised $1.8B Series B in 2021 led by Tiger Global and Bill Gates; SPARC commissioning targeted for 2027 with first net energy gain. Largest private fusion company by funding. |
Helion Energy helionenergy.com | Everett | Pulsed magnetic-confinement fusion company. Sam Altman is the largest investor. Signed a 50MW power purchase agreement with Microsoft in 2023 for delivery by 2028. Raised $425M Series F in 2024 with $1.7B additional commitments tied to milestones. |
TAE Technologies tae.com | Foothill Ranch | Field-reversed-configuration fusion company. Has raised over $1.2B to date. Diversified into power management and proton-boron fusion research. |
Ginkgo Bioworks ginkgobioworks.com | Boston | Listed on NYSE as DNA. Synthetic biology foundry; stock traded down over 95% from SPAC peak. Restructured in 2024 with significant headcount reductions to extend runway. |
Sila Nano silanano.com | Alameda | Silicon-anode battery materials. Mercedes-Benz EQG is the anchor automotive customer. Raised $375M in 2024 to scale its Moses Lake, WA facility. |
Neuralink neuralink.com | Fremont | Elon Musk's brain-computer interface company. First human Telepathy implant in January 2024; second and third patients implanted through 2024-25. Last valued at $5B in 2023. |
CFO-as-a-service, on your terms.
Fractional CFO services scoped to your stage - a few days a month or embedded through a raise.
Key DeepTech market trends
Quantum logical-qubit breakthroughs, the fusion private capital wave and photonic-AI acceleration are reshaping deeptech right now.
Quantum logical-qubit breakthroughs
Google demonstrated a fault-tolerant logical qubit on Willow in December 2024; Microsoft and Atom Computing demonstrated 28 entangled logical qubits in late 2024; IBM published a refined roadmap targeting 200 logical qubits by 2029. The narrative has shifted from physical qubit counts to fault-tolerance milestones. Dated December 2024.
Fusion private capital wave
Helion raised $425M Series F in early 2024; Pacific Fusion raised $900M in October 2024 from General Catalyst, Lightspeed and Lowercarbon; Realta Fusion raised $36M Series A in 2024; the Fusion Industry Association now tracks over 40 private fusion companies with cumulative private capital above $7B. Dated October 2024.
Photonic-AI acceleration
Lightmatter raised $400M Series D at $4.4B valuation in late 2024; Celestial AI raised $175M Series C in 2025 led by Fidelity at over $2.5B; Ayar Labs raised $155M Series D in late 2024. NVIDIA's photonic switch roadmap and Broadcom's CPO platform validate the category for hyperscale AI workloads. Dated March 2025.
US CHIPS Act and Microelectronics Commons
The US National Semiconductor Technology Center (NSTC) and the $2B Microelectronics Commons program funded eight regional hubs in 2024-25. The Center for Quantum Engineering, NEXUS for advanced packaging and other consortia are pulling DeepTech R&D into a US-government-coordinated framework. Dated February 2025.
PsiQuantum-Australia utility-scale deal
PsiQuantum signed a roughly AUD 940M (around USD 620M) deal with the Australian federal and Queensland state governments in April 2024 to build a utility-scale photonic quantum computer in Brisbane. Largest single sovereign commitment to a private quantum company. Dated April 2024.
Ginkgo and synbio reset
Ginkgo Bioworks restructured in 2024 with around 35% workforce reductions and pulled its near-term revenue guidance, marking a broader synbio reset. Zymergen folded into Ginkgo in 2022 after its $3B SPAC peak collapsed. The synbio platform thesis is being rebuilt around narrower applications. Dated August 2024.
Similar verticals to DeepTech
Explore niches like 3D printing, automation & robotics, test & measurement and sensors & monitoring.
Explore other sectors
We know tech inside & out.
We live and breath tech - true understanding of how startups operate is fundamental at what we do.
Recent insights across DeepTech and beyond
Talk to us
Schedule a call to get a health check on your business and see how we could help.
Fractional CFO
- Fractional CFO for Software
- Fractional CFO for AI & ML
- Fractional CFO for Fintech
- Fractional CFO for Consumer internet
- Fractional CFO for Digital media
- Fractional CFO for E-commerce & marketplaces
- Fractional CFO for Consumer products
- Fractional CFO for Mobility
- Fractional CFO for Digital health
- Fractional CFO for Industrial technology
- Fractional CFO for Digital infrastructure
- Fractional CFO for IT services
Stages
Countries
- UK Fractional CFO
- Ireland Fractional CFO
- France Fractional CFO
- Germany Fractional CFO
- Spain Fractional CFO
- Portugal Fractional CFO
- Italy Fractional CFO
- Netherlands Fractional CFO
- Belgium Fractional CFO
- Switzerland Fractional CFO
- Austria Fractional CFO
- Denmark Fractional CFO
- Sweden Fractional CFO
- Norway Fractional CFO
- Finland Fractional CFO
- Poland Fractional CFO
- Estonia Fractional CFO
- US Fractional CFO
- Canada Fractional CFO
- Mexico Fractional CFO
- Brazil Fractional CFO
- UAE Fractional CFO
- Australia Fractional CFO
Cities
- London Fractional CFO
- Dublin Fractional CFO
- Paris Fractional CFO
- Berlin Fractional CFO
- Madrid Fractional CFO
- Lisbon Fractional CFO
- Milan Fractional CFO
- Amsterdam Fractional CFO
- Brussels Fractional CFO
- Zurich Fractional CFO
- Vienna Fractional CFO
- Copenhagen Fractional CFO
- Stockholm Fractional CFO
- Oslo Fractional CFO
- Helsinki Fractional CFO
- Warsaw Fractional CFO
- Tallinn Fractional CFO
- New York Fractional CFO
- Toronto Fractional CFO
- Mexico City Fractional CFO
- São Paulo Fractional CFO
- Dubai Fractional CFO
- Sydney Fractional CFO






























